Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01116388 · ClinicalTrials.gov registry record · NA

A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
65
Enrollment target

NCT01116388: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01116388 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01116388, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target

Study Summary

Doctors at MassGeneral Hospital for Children (MGHfC) are doing a research study to learn if a gluten free-dairy free (GFCF) diet is helpful in improving gastrointestinal symptoms associated with autism. Hypothesis: The gluten free/casein free diet (GFCF) will result in a higher proportion of subjects having reduction in gastrointestinal (GI) symptoms associated with autism spectrum disorders (ASD). Primary Study Objective: * To assess the effect of a GFCF diet on GI symptoms associated with ASD. Secondary Objectives: * To assess if improvements in GI symptoms result in improvements in autistic behavior when using a GFCF diet in the dietary management of GI symptoms associated with ASD * To determine the nutritional impact of a GFCF restrictive diet * To assess the role of food allergies in the manifestation of GI symptoms This is a 14-week study that requires between 5 \& 9 office visits. All study related activities -including physical exams, blood samples and allergy testing - and an amino acid based supplement drink, are at no cost. Research study visits will take place at MGHfC in Boston, or at Newton Wellesley Hospital in Newton, or at Lurie Center/LADDERS in Lexington.

Interventions

  • OTHER GFCF product with GFCF diet
  • OTHER product containing gluten and casein (milk protein) with GFCF diet

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2010-04
Est. Completion 2015-04
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01116388

The ClinicalTrials.gov registry entry for NCT01116388 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which GFCF product with GFCF diet is the first listed.

NCT01116388 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01116388 about?

NCT01116388 is a clinical study titled "A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders". Doctors at MassGeneral Hospital for Children (MGHfC) are doing a research study to learn if a gluten free-dairy free (GFCF) diet is helpful in improving gastrointestinal symptoms associated with autism. Hypothesis: The gluten free/casein free diet (GFCF) will result in a higher proportion of subjec...

What is the current status of trial NCT01116388?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2010-04. Estimated completion is 2015-04.

What interventions are being tested in trial NCT01116388?

The interventions under investigation include: GFCF product with GFCF diet (OTHER), product containing gluten and casein (milk protein) with GFCF diet (OTHER).

Who is sponsoring clinical trial NCT01116388?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.